Schedule 13G ownership disclosure

Biohaven Pharmactl Hldg Co

Security class unavailable · CUSIP: G11196105

Event date: 2022-04-29

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
7,075,514
Percent of class
10.0000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001422849-22-000144
Form type
SC 13G/A
Filer
Biohaven Pharmaceutical Holding Co Ltd.
CIK
CIK 1689813
Filed
May 10, 2022
Reporting period
Apr 29, 2022
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub